July 7: Shareholders don’t seem very impressed by the sight of Aviva getting all AmerUs again. After our overnight scoop, the talks were confirmed this morning. Aviva shares are off 3.5 per cent. We’ll tell you why in tomorrow’s paper, or you can read Lex now. You may remember – we certainly do – that in January, Aviva denied a Guardian story about a deal with AmerUs, saying it was not in talks with the company and had not made any sort of proposal. Amazing how things turn out.

Still on the theme of British companies going to America, tomorrow being a Saturday, you can expect us to do more on Burberry’s plans to expand in the Midwest.

Standard Life has priced its shares at 230p each, bang in line with our prediction this morning.

The news from Isoft just gets worse. It is delaying its preliminary results, partly to allow more time for discussions over its banking facilities. The share price, which has been the softest thing about Isoft for months, is off another 15 per cent.

We’ll also tell you more than Peter Smith was able to in his scoop this morning about who will take over from Richard Sharp at the top of Goldman Sachs’ private equity arm. Those interested in private equity should make sure they read Jane Martinson’s fabulous interview in The Guardian with Sir Ronald Cohen, founder of Apax.

To make or read a comment, click here

For previous blogs, click here

If you would like to unsubscribe from this email, please email client.support@ft.com and insert ‘unsubscribe’ in the subject line

Get alerts on US when a new story is published

Copyright The Financial Times Limited 2022. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Comments have not been enabled for this article.

Follow the topics in this article